PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.66%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.38%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-15.27%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-23.77%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-15.66%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-15.66%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-15.66%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
74.19%
10Y revenue/share CAGR at 50-75% of 9843.T's 136.90%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
66.93%
5Y revenue/share CAGR similar to 9843.T's 64.82%. Walter Schloss might see both companies benefiting from the same mid-term trends.
36.33%
3Y revenue/share CAGR similar to 9843.T's 37.76%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
197.70%
Below 50% of 9843.T's 693.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
61.57%
Below 50% of 9843.T's 127.11%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
48.90%
3Y net income/share CAGR 75-90% of 9843.T's 62.28%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
222.31%
10Y equity/share CAGR at 75-90% of 9843.T's 288.31%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
133.90%
5Y equity/share CAGR 1.25-1.5x 9843.T's 105.70%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
65.83%
3Y equity/share CAGR above 1.5x 9843.T's 40.14%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-10.00%
Negative 5Y dividend/share CAGR while 9843.T stands at 108.89%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
50.00%
3Y dividend/share CAGR at 75-90% of 9843.T's 56.67%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
147.76%
Our AR growth while 9843.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
8.38%
We show growth while 9843.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.02%
Asset growth at 50-75% of 9843.T's 1.71%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.65%
Similar to 9843.T's 4.06%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-7.61%
We’re deleveraging while 9843.T stands at 1.91%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.36%
We expand SG&A while 9843.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.